YCY
NYSE · N/A
Aa Mission Acquisition-A
$10.06
+0.01 (+0.09%)
Open$10.05
Previous Close$10.05
Day High$10.06
Day Low$10.05
52W High$47.24
52W Low$20.25
Volume—
Avg Volume679.6K
Market Cap147.06M
P/E Ratio—
EPS$-0.14
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 39.01M | 40.32M | 32.67M |
| Net Income | 1.80M | 2.30M | 1.57M |
| Profit Margin | 4.6% | 5.7% | 4.8% |
| EBITDA | 3.33M | 3.18M | 2.52M |
| Free Cash Flow | 1.88M | 2.00M | 1.33M |
| Rev Growth | +9.1% | -6.2% | +4.8% |
| Debt/Equity | 0.57 | 0.61 | 0.48 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | -0.20% | — | 655.09M |
| CCCX | Churchill Capital Corp X-A | $11.66 | +8.57% | — | 606.90M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |